Crossref
journal-article
Public Library of Science (PLoS)
PLoS Genetics (340)
References
97
Referenced
76
10.1038/nm1113
/ Nat Med / Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs by MS Forman (2004)10.1146/annurev.biochem.75.101304.123901
/ Annu Rev Biochem / Protein misfolding, functional amyloid, and human disease by F Chiti (2006)10.1242/jcs.051672
/ J Cell Sci / Prion-like disorders: blurring the divide between transmissibility and infectivity by M Cushman (2010)10.1080/13506120500032196
/ Amyloid / Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis by P Westermark (2005)10.1016/j.cell.2012.09.038
/ Cell / Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients by ME DeSantis (2012)10.1111/j.1365-2958.2008.06135.x
/ Mol Microbiol / Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation by P Tessarz (2008)10.1016/j.cell.2007.10.047
/ Cell / Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104 by P Wendler (2007)10.1016/j.molcel.2009.02.026
/ Mol Cell / Motor mechanism for protein threading through Hsp104 by P Wendler (2009)10.1126/science.2188365
/ Science / HSP104 required for induced thermotolerance by Y Sanchez (1990)10.1038/372475a0
/ Nature / Protein disaggregation mediated by heat-shock protein Hsp104 by DA Parsell (1994)10.1016/j.cell.2009.02.044
/ Cell / A systematic survey identifies prions and illuminates sequence features of prionogenic proteins by S Alberti (2009)10.1126/science.1098007
/ Science / Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers by J Shorter (2004)10.1016/j.molcel.2006.05.042
/ Mol Cell / Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities by J Shorter (2006)10.1038/emboj.2012.264
/ EMBO J / Metazoan Hsp70 machines use Hsp110 to power protein disaggregation by H Rampelt (2012)10.1371/journal.pone.0026319
/ PLoS One / The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system by J Shorter (2011)10.1371/journal.pbio.1001346
/ PLoS Biol / Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans by ML Duennwald (2012){'key': 'ref17', 'first-page': '1', 'article-title': 'Applying Hsp104 to protein-misfolding disorders', 'volume': '88', 'author': 'S Vashist', 'year': '2010', 'journal-title': 'Biochem Cell Biol'}
/ Biochem Cell Biol / Applying Hsp104 to protein-misfolding disorders by S Vashist (2010)10.1159/000109760
/ Neurosignals / Hsp104: a weapon to combat diverse neurodegenerative disorders by J Shorter (2008)10.1186/1750-1172-6-35
/ Orphanet J Rare Dis / Machado-Joseph Disease: from first descriptions to new perspectives by C Bettencourt (2011)10.1016/B978-0-444-51892-7.00027-9
/ Handb Clin Neurol / Machado-Joseph disease/spinocerebellar ataxia type 3 by H Paulson (2012)10.1002/ana.410410408
/ Ann Neurol / Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain by HL Paulson (1997)10.1016/S0896-6273(00)80943-5
/ Neuron / Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3 by HL Paulson (1997)10.1038/ng0793-300
/ Nat Genet / The gene for Machado-Joseph disease maps to human chromosome 14q by Y Takiyama (1993)10.1074/jbc.M803692200
/ J Biol Chem / The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains by BJ Winborn (2008)10.1038/ncb2200
/ Nat Cell Biol / The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis by K Kuhlbrodt (2011)10.1016/S0014-5793(03)00748-8
/ FEBS Lett / Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a flexible tail by L Masino (2003)10.1016/j.jmb.2007.02.058
/ J Mol Biol / Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein by AM Ellisdon (2007)10.1074/jbc.M601470200
/ J Biol Chem / The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step by AM Ellisdon (2006)10.1016/j.jmb.2004.09.065
/ J Mol Biol / Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3 by L Masino (2004)10.1038/emboj.2008.194
/ EMBO J / Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions by J Shorter (2008)10.1172/JCI35781
/ J Clin Invest / Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease by C Lo Bianco (2008)10.1038/mt.sj.6300141
/ Mol Ther / Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease by V Perrin (2007)10.1073/pnas.100107297
/ Proc Natl Acad Sci U S A / Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans by SH Satyal (2000)10.1093/hmg/ddi372
/ Hum Mol Genet / Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease by C Vacher (2005)10.1016/j.neulet.2006.05.066
/ Neurosci Lett / Infection by ME7 prion is not modified in transgenic mice expressing the yeast chaperone Hsp104 in neurons by F Dandoy-Dron (2006)10.1021/bi0493766
/ Biochemistry / Saccharomyces cerevisiae Hsp104 enhances the chaperone capacity of human cells and inhibits heat stress-induced proapoptotic signaling by DD Mosser (2004)10.1523/JNEUROSCI.4778-07.2008
/ J Neurosci / Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease by K Trinh (2008)10.1242/dev.118.2.401
/ Development / Targeted gene expression as a means of altering cell fates and generating dominant phenotypes by AH Brand (1993)10.1523/JNEUROSCI.5894-09.2010
/ J Neurosci / TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97 by GP Ritson (2010)10.1016/S0092-8674(00)81200-3
/ Cell / Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila by JM Warrick (1998)10.1016/j.molcel.2005.02.030
/ Mol Cell / Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism by JM Warrick (2005)10.1074/jbc.M611914200
/ J Biol Chem / Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3 by A Haacke (2007)10.1093/hmg/ddp456
/ Hum Mol Genet / Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3 by J Jung (2009)10.1038/502
/ Nat Genet / Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 by CJ Cummings (1998)10.1038/70532
/ Nat Genet / Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 by JM Warrick (1999)10.1093/hmg/9.19.2811
/ Hum Mol Genet / Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila by HY Chan (2000)10.1073/pnas.140202897
/ Proc Natl Acad Sci U S A / Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils by PJ Muchowski (2000){'key': 'ref48', 'first-page': 'e838', 'article-title': 'Screening for amyloid aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis', 'volume': '17', 'author': 'R Halfmann', 'year': '2008', 'journal-title': 'J Vis Exp'}
/ J Vis Exp / Screening for amyloid aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis by R Halfmann (2008)10.1128/jb.175.20.6484-6491.1993
/ J Bacteriol / Genetic evidence for a functional relationship between Hsp104 and Hsp70 by Y Sanchez (1993)10.1007/s10048-009-0216-y
/ Neurogenetics / Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3) by C Bettencourt (2010)10.1371/journal.pone.0013695
/ PLoS One / Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties by GM Harris (2010)10.1038/nsmb.2031
/ Nat Struct Mol Biol / Dominant prion mutants induce curing through pathways that promote chaperone-mediated disaggregation by S DiSalvo (2011)10.1002/gene.10133
/ Genesis / Conditional expression of UAS-transgenes in the adult eye with a new gene-switch vector system by G Roman (2002)10.1073/pnas.221303298
/ Proc Natl Acad Sci U S A / A conditional tissue-specific transgene expression system using inducible GAL4 by T Osterwalder (2001)10.1371/journal.pbio.1001052
/ PLoS Biol / A yeast model of FUS/TLS-dependent cytotoxicity by S Ju (2011)10.1038/ng.2434
/ Nat Genet / Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models by M Armakola (2012)10.1371/journal.pbio.1000614
/ PLoS Biol / Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS by Z Sun (2011)10.1038/nrg1616
/ Nat Rev Genet / Prions as adaptive conduits of memory and inheritance by J Shorter (2005)10.1016/j.chembiol.2012.09.013
/ Chem Biol / Hsp104 drives “protein-only” positive selection of Sup35 prion strains encoding strong [PSI(+)] by ME DeSantis (2012)10.1073/pnas.0812083106
/ Proc Natl Acad Sci U S A / Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity by Y Nekooki-Machida (2009)10.1016/j.cell.2010.11.050
/ Cell / Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions by H Olzscha (2011)10.4161/cc.10.10.15432
/ Cell Cycle / Aberrant protein interactions in amyloid disease by RM Vabulas (2011)10.1073/pnas.0802593105
/ Proc Natl Acad Sci U S A / Chaperone-dependent amyloid assembly protects cells from prion toxicity by PM Douglas (2008)10.1016/j.semcdb.2011.03.011
/ Semin Cell Dev Biol / Amyloid in neurodegenerative diseases: friend or foe? by KJ Wolfe (2011)10.1038/nature02261
/ Nature / Protein folding and misfolding by CM Dobson (2003)10.1073/pnas.170280697
/ Proc Natl Acad Sci U S A / Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease by J Carmichael (2000)10.1074/jbc.273.15.9158
/ J Biol Chem / Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract by CL Wellington (1998)10.1016/j.cell.2006.04.026
/ Cell / Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin by RK Graham (2006)10.1073/pnas.0604547103
/ Proc Natl Acad Sci U S A / Flanking sequences profoundly alter polyglutamine toxicity in yeast by ML Duennwald (2006)10.1016/j.bpj.2011.02.056
/ Biophys J / The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils by L Masino (2011)10.1073/pnas.0501732102
/ Proc Natl Acad Sci U S A / The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition by G Nicastro (2005)10.1038/nrn1587
/ Nat Rev Neurosci / Modulation of neurodegeneration by molecular chaperones by PJ Muchowski (2005)10.1016/j.febslet.2009.04.029
/ FEBS Lett / The role of molecular chaperones in human misfolding diseases by SA Broadley (2009)10.1074/jbc.M505524200
/ J Biol Chem / Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice by HY Shen (2005)10.1016/j.bbrc.2004.07.021
/ Biochem Biophys Res Commun / Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro by PJ McLean (2004)10.1038/nm1102-1185
/ Nat Med / Pharmacological prevention of Parkinson disease in Drosophila by PK Auluck (2002)10.1038/nchembio.1140
/ Nat Chem Biol / Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation by AM Wang (2012)10.1016/S0197-4580(02)00065-9
/ Neurobiol Aging / Staging of brain pathology related to sporadic Parkinson's disease by H Braak (2003)10.1001/jama.283.12.1571
/ JAMA / Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline by J Naslund (2000)10.1016/S0092-8674(00)80513-9
/ Cell / Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation by SW Davies (1997)10.1056/NEJMoa0802268
/ N Engl J Med / Effect of gene therapy on visual function in Leber's congenital amaurosis by JW Bainbridge (2008)10.1056/NEJMoa012616
/ N Engl J Med / Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy by S Hacein-Bey-Abina (2002)10.1056/NEJMoa0802315
/ N Engl J Med / Safety and efficacy of gene transfer for Leber's congenital amaurosis by AM Maguire (2008)10.1073/pnas.0706006104
/ Proc Natl Acad Sci U S A / Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease by A Feigin (2007)10.1016/S0140-6736(07)60982-9
/ Lancet / Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial by MG Kaplitt (2007)10.1016/S0140-6736(07)60957-X
/ Lancet / Gene therapy for Parkinson's disease: early data by AJ Stoessl (2007)10.1038/nrneurol.2013.103
/ Nat Rev Neurol / Progress in gene therapy for neurological disorders by M Simonato (2013)10.1007/s13311-013-0191-8
/ Neurotherapeutics / Gene Therapy for Misfolding Protein Diseases of the Central Nervous System by W San Sebastian (2013)10.1038/359832a0
/ Nature / Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin by G Schiavo (1992)10.1021/bi201490t
/ Biochemistry / Retargeted clostridial neurotoxins as novel agents for treating chronic diseases by FL Yeh (2011)10.1056/NEJM199907083410209
/ N Engl J Med / One man's poison–clinical applications of botulinum toxin by M Hallett (1999)10.1016/j.toxicon.2009.01.022
/ Toxicon / Botulinum toxin for the management of adult patients with upper motor neuron syndrome by A Esquenazi (2009)10.1002/mds.22452
/ Mov Disord / Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review by AE Elia (2009)10.1097/00019052-199908000-00012
/ Curr Opin Neurol / Botulinum toxin in motor disorders by AR Bentivoglio (1999)10.1002/jnr.21171
/ J Neurosci Res / The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon by SL Osborne (2007)10.1242/dev.120.8.2121
/ Development / Expression of baculovirus P35 prevents cell death in Drosophila by BA Hay (1994)10.18632/aging.100018
/ Aging (Albany NY) / A screen of apoptosis and senescence regulatory genes for life span effects when over-expressed in Drosophila by J Shen (2009)
Dates
Type | When |
---|---|
Created | 11 years, 11 months ago (Sept. 5, 2013, 5:22 p.m.) |
Deposited | 3 years, 5 months ago (March 5, 2022, 11:36 a.m.) |
Indexed | 5 days, 11 hours ago (Aug. 27, 2025, 11:39 a.m.) |
Issued | 11 years, 11 months ago (Sept. 5, 2013) |
Published | 11 years, 11 months ago (Sept. 5, 2013) |
Published Online | 11 years, 11 months ago (Sept. 5, 2013) |
@article{Cushman_Nick_2013, title={Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model}, volume={9}, ISSN={1553-7404}, url={http://dx.doi.org/10.1371/journal.pgen.1003781}, DOI={10.1371/journal.pgen.1003781}, number={9}, journal={PLoS Genetics}, publisher={Public Library of Science (PLoS)}, author={Cushman-Nick, Mimi and Bonini, Nancy M. and Shorter, James}, editor={Lu, Bingwei}, year={2013}, month=sep, pages={e1003781} }